A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
University of Nebraska
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Universität des Saarlandes
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
Ruijin Hospital
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Miami
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
Samsung Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Northside Hospital, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Northside Hospital, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)